Ki-Cheong Park

14PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 09, 2025
Identification of new small molecules for selective inhibition of SERCA 1 in patient-derived metastatic papillary thyroid cancer.

Seok-Mo Kim, Keunwan Park, Hyeok Jun Yun

|Oct 16, 2024
New Small-Molecule SERCA Inhibitors Enhance Treatment Efficacy in Lenvatinib-Resistant Papillary Thyroid Cancer.

Jungmin Kim, Hang-Seok Chang, Hyeok Jun Yun

|Nov 25, 2023
Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer.

Yuna Kim, Hyeok Jun Yun, Kyung Hwa Choi

|Apr 28, 2023
Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma.

Hang-Seok Chang, Yonjung Kim, So Young Lee

|Feb 02, 2023
PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived models.

Ki Cheong Park, Jung Min Kim, Sang Yong Kim

Pageof 3